Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...
FDA Commissioner Marty Makary and biologics chief Vinay Prasad have sketched out the agency’s first real blueprint for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback